Altimmune, Inc.
ALT · NASDAQ
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Altimmune, Inc. (ALT) is a biotechnology company focused on the development of immunotherapies and therapeutic products. The company specializes in the development of vaccines and therapeutics aimed at boosting the immune system and combating various infectious diseases. Their research spans areas such as respiratory diseases, hepatitis B, and other health challenges. Altimmune strives to innovate in the field of immunotherapy and introduce new treatment possibilities. The company leverages modern technologies and scientific research to achieve its goals. Investors interested in the biotechnology sector and healthcare innovations might see potential in Altimmune, Inc. (ALT) shares for growth in this dynamic field.
Sector
Healthcare
Industry
Biotechnology
CEO
Jerome Benedict Durso
Employees
57
Headquarters
Gaithersburg
Upcoming events
Earnings
Upcoming earnings report